162 related articles for article (PubMed ID: 3456076)
1. Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis.
Friedland GH; Saltzman BR; Rogers MF; Kahl PA; Lesser ML; Mayers MM; Klein RS
N Engl J Med; 1986 Feb; 314(6):344-9. PubMed ID: 3456076
[TBL] [Abstract][Full Text] [Related]
2. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
[TBL] [Abstract][Full Text] [Related]
3. Occupational risk of the acquired immunodeficiency syndrome among health care workers.
McCray E
N Engl J Med; 1986 Apr; 314(17):1127-32. PubMed ID: 3485769
[TBL] [Abstract][Full Text] [Related]
4. Acquired immune deficiency syndrome (AIDS)--recommendations of IMAP.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1986 Jun; 20(3):3-4. PubMed ID: 12268332
[TBL] [Abstract][Full Text] [Related]
5. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL
JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375
[TBL] [Abstract][Full Text] [Related]
6. The Walter Reed staging classification for HTLV-III/LAV infection.
Redfield RR; Wright DC; Tramont EC
N Engl J Med; 1986 Jan; 314(2):131-2. PubMed ID: 2934633
[TBL] [Abstract][Full Text] [Related]
7. Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome.
Kaplan JE; Oleske JM; Getchell JP; Kalyanaraman VS; Minnefor AB; Zabala-Ablan M; Joshi V; Denny T; Cabradilla CD; Rogers MF
Pediatr Infect Dis; 1985; 4(5):468-71. PubMed ID: 2995933
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire.
Mann JM; Quinn TC; Francis H; Nzilambi N; Bosenge N; Bila K; McCormick JB; Ruti K; Asila PK; Curran JW
JAMA; 1986 Aug; 256(6):721-4. PubMed ID: 3014178
[TBL] [Abstract][Full Text] [Related]
9. [AIDS in Africa].
Sansone R; Carobbi S; Alloro G; Strigini P
Ann Ig; 1989; 1(5):1057-66. PubMed ID: 2483891
[TBL] [Abstract][Full Text] [Related]
10. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex.
Resnick L; diMarzo-Veronese F; Schüpbach J; Tourtellotte WW; Ho DD; Müller F; Shapshak P; Vogt M; Groopman JE; Markham PD
N Engl J Med; 1985 Dec; 313(24):1498-504. PubMed ID: 2999592
[TBL] [Abstract][Full Text] [Related]
11. Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors.
Feorino PM; Jaffe HW; Palmer E; Peterman TA; Francis DP; Kalyanaraman VS; Weinstein RA; Stoneburner RL; Alexander WJ; Raevsky C
N Engl J Med; 1985 May; 312(20):1293-6. PubMed ID: 2985992
[TBL] [Abstract][Full Text] [Related]
12. A classification of HTLV-III infection based on 75 cases seen in a suburban community.
Kaplan MH; Pahwa SG; Popovic M; Sarngadharan MG; Gallo RC
Cancer Res; 1985 Sep; 45(9 Suppl):4655s-4658s. PubMed ID: 2990703
[TBL] [Abstract][Full Text] [Related]
13. Risk of human immunodeficiency virus type 1 infection among sexual and nonsexual household contacts of persons with congenital clotting disorders.
Lusher JM; Operskalski EA; Aledort LM; Dietrich SL; Gjerset GF; Hilgartner MW; Koerper MA; Pegelow CH; Lee H; Mosley JW
Pediatrics; 1991 Aug; 88(2):242-9. PubMed ID: 1861921
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
15. Lymphadenopathic type of Kaposi's sarcoma in a Ugandan child seropositive for LAV/HTLV-III antibodies.
Marquart KH; Müller HA; Hartter P; Oku JC; Ayuko WO
J Trop Med Hyg; 1987 Apr; 90(2):93-4. PubMed ID: 3470530
[TBL] [Abstract][Full Text] [Related]
16. Antibody to human lymphotropic virus type III: immunologic status of homosexual contacts of patients with the acquired immunodeficiency syndrome and the acquired immunodeficiency-related complex.
Goldsmith JM; Kalish SB; Ostrow DG; Britz J; Chmiel JS; Wallemark CB; Phair JP
Sex Transm Dis; 1987; 14(1):44-7. PubMed ID: 2951878
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of heterosexual partners, children, and household contacts of adults with AIDS.
Fischl MA; Dickinson GM; Scott GB; Klimas N; Fletcher MA; Parks W
JAMA; 1987 Feb; 257(5):640-4. PubMed ID: 3467077
[TBL] [Abstract][Full Text] [Related]
18. Lack of transmission of human immunodeficiency virus from infected children to their household contacts.
Rogers MF; White CR; Sanders R; Schable C; Ksell TE; Wasserman RL; Bellanti JA; Peters SM; Wray BB
Pediatrics; 1990 Feb; 85(2):210-4. PubMed ID: 2296509
[TBL] [Abstract][Full Text] [Related]
19. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
20. Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state.
Laurence J; Brun-Vezinet F; Schutzer SE; Rouzioux C; Klatzmann D; Barré-Sinoussi F; Chermann JC; Montagnier L
N Engl J Med; 1984 Nov; 311(20):1269-73. PubMed ID: 6092953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
